| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.9M | — | -18.5% |
| Cost of Revenue | $7.4M | — | -22.7% |
| Gross Profit | $23.5M | — | -17.1% |
| R&D Expense | $9.5M | — | -8.6% |
| SG&A Expense | $31.9M | — | +11.2% |
| Operating Income | -$17.8M | — | -67.0% |
| Interest Expense | $3K | — | -50.0% |
| Pre-tax Income | -$15.9M | — | -94.3% |
| Income Tax | $6K | — | -66.7% |
| Net Income | -$15.9M | — | -93.9% |
| EPS (Basic) | -$0.38 | — | -90.0% |
| EPS (Diluted) | -$0.38 | — | -90.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.6M | -11.9% | -37.2% |
| Short-term Investments | $200.3M | -3.8% | -0.5% |
| Accounts Receivable | $22.4M | -4.0% | -27.5% |
| Inventory | $34.9M | +10.5% | +47.9% |
| Current Assets | $279.2M | -2.9% | -3.2% |
| Total Assets | $304.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | — | -23.3% |
| Capital Expenditures | $759K | — | +32.0% |
| Investing Cash Flow | $8.8M | — | -57.6% |
| Financing Cash Flow | -$336K | — | +54.3% |
| Free Cash Flow | -$11.7M | — | -23.8% |
| -2.9% |
| Current Liabilities | $27.4M | +4.3% | +20.4% |
| Total Liabilities | $36.7M | +1.6% | +8.8% |
| Stockholders' Equity | $267.3M | -3.0% | -4.3% |